Radiofrequency Market Trends and Segments Forecast To 2028

The global radiofrequency market size was valued at USD 4,621.2 million in 2021 and is poised to grow at a significant CAGR of 11.6% during the forecast period from 2022 to 2028. Radiofrequency ablation (RFA) is a medical procedure that employs heat energy to alleviate pain or reduce the size of tumors and other growths in the body. RFA is used to treat various medical conditions, such as malignant or benign tumors, chronic back or neck pain, and chronic venous insufficiency in the legs. The procedure is comparable to needle biopsy and involves inserting a needle-like probe into the patient's body. Once the device is correctly inserted, radiofrequency waves are transmitted from the probe to the surrounding tissue in the intended area, causing the death of nearby cells. As soon as the cells are destroyed, the immune system begins to eliminate them from the body, causing an internal reaction that results in the reduction of the nodule size. To position the tip of the probe accurately, supportive devices like imaging techniques or ultrasound are employed. This technique is minimally invasive, patient-friendly, and can be performed in a regular hospital setting or even in the patient's home. After a successful procedure, the patient can resume daily activities within 24 hours without a prolonged postoperative recovery period.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/radiofrequency-market/

Radiofrequency Market Growth Factors:
The global market for radiofrequency ablation devices is expected to experience growth due to the rising number of cancer patients and increased investments in cancer treatments. RFA is frequently used for treating cancers in organs such as the kidney, lungs, liver, adrenal gland, thyroid, and pancreas, but is usually only recommended for high-risk patients who cannot undergo surgery. Cancer is one of the leading causes of death globally, and while there is no permanent cure, the medical sector is working to develop effective treatments. Until a cure is found, healthcare professionals employ various methods to manage or eliminate cancer cells, including RFA. This procedure involves a radiologist using imaging tests to locate the specific site where the probe will be inserted into the cancerous tissue. The global market for RFA may continue to grow as more regional regulatory bodies, such as the US Food and Drug Administration and the European Commission, approve new innovations and discoveries for use with patients.

Radiofrequency Market Segmentation:
1) By Type: Disposable, Capital, Reusable Equipment.
2) Device Type: Generators, Electrodes, Applicators, Probes, Cannulas, Needles.
3) Ablation Type: Unipolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation.
4) Application: Arrhythmia, Obstructive Sleep Apnea, Cancer, Pain Management, Dermatology, Gynecology.
5) End User: Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers.

Radiofrequency Market Regional Analysis:
With a market share of 33.67% in 2022 and a projected growth rate of 16.5% during the forecast period, Asia Pacific emerged as the top regional market for Radio Frequency components. The region's growth is attributed to the surging demand for such components in various consumer electronics applications. The increasing adoption of power amplifiers and duplexers in mobile phones, tablets, laptops, notebooks, and other devices is driving market growth. Radio Frequency components are crucial for frequency up and down conversion, with the radio frequency down converter used to convert the radio frequency signal to a baseband signal for use in GSM.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=55274

Key players in the Radiofrequency Market Abbott Laboratories, ALMA Lasers (Sisram Medical Ltd), AtriCure, Inc., Medtronic plc, Stryker, Conmed Corporation, HelpMeSee, Smith & Nephew plc
Boston Scientific Corporation, Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.